German doctors and politicians disagree on reimbursement for homoeopathyBMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c3902 (Published 20 July 2010) Cite this as: BMJ 2010;341:c3902
- Annette Tuffs
A recent spate of demands in the United Kingdom that homoeopathic treatments no longer be provided on the NHS has prompted a debate in Germany about the place of homoeopathy in its health service.
Despite the fact that some German pharmacology experts would like to see public health insurers cease paying for it, the German Medical Association (Bundesärztekammer) has come out in favour of keeping its reimbursement.
The association’s president, Jörg-Dietrich Hoppe, has defended homoeopathic treatment in an official statement. He said that despite the lack of scientific evidence for its effectiveness homoeopathy was an important part of medicine. It was especially effective in treating travel sickness and general malaise but also in preventing disease, he said.
He was backed by the federal health minister, Philipp Rösler, …
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.